Frontiers | Complement Factor I Variants in Complement-Mediated Renal Diseases
Biomedicines | Free Full-Text | A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice
Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning | Science
SEC Filing - Kiromic BioPharma, Inc.
Cells | Free Full-Text | Interconnections between Inflammageing and Immunosenescence during Ageing
SEC Filing - Kiromic BioPharma, Inc.
PharmaBoardroom - MolMed Italy
Instil Bio Inc.: Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference - MoneyController (ID 1461903)
Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning | Science
SEC Filing | Context Therapeutics Inc.
Biocept Inc.: Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics - MoneyController (ID 1590202)
Brainstorm Cell Therapeutics: What's Left After Recent Trial Failure (NASDAQ:BCLI) | Seeking Alpha
Brainstorm Cell Therapeutics Inc
tm2025286-21_424b4 - none - 19.1980028s
Haemonetics Announces Sale Of U.S. Blood Donor Management Software Solution Assets To The GPI Group
Italy's stem-cell pioneer at risk
CD8+ T cell differentiation and dysfunction in cancer | Nature Reviews Immunology
SEC Filing | Context Therapeutics Inc.
Cell therapy industry 2022 - Labiotech.eu
The Domestic Sector - Italy Life Sciences 2021
Tapping the keg of discovery to advance T cell therapy | Nature Immunology
Cells | Free Full-Text | The Complement System in Kidney Transplantation
Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway | Nature Communications
SEC Filing - Kiromic BioPharma, Inc.
form424b4_005.jpg
SEC Filing - Kiromic BioPharma, Inc.
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds | Nature Protocols
forms-1_004.jpg
SEC Filing | Context Therapeutics Inc.
Cellular and molecular waypoints along the path of T cell exhaustion | Science Immunology
Cells | Free Full-Text | Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and C
The evolving role of tissue-resident memory T cells in infections and cancer | Science Advances
Will MolMed soon have its first Cell therapy on the Market?
SEC Filing - Sorrento Therapeutics
Cells | Free Full-Text | Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies
La rete tra le 281 società quotate in Borsa. | Download Scientific Diagram
CellPly, the technology that revolutionizes the characterization of cell therapies, closed two million round | Italian Angels for Growth
Aging Cell: Vol 20, No 2
SEC Filing - Kiromic BioPharma, Inc.
Innovative Therapies Days 2023 - b2match
tm2025286-3_s1 - none - 15.859984s
SEC Filing | Context Therapeutics Inc.
forms-1_006.jpg
SEC Filing – Investors – Gamida Cell Ltd.
Frontiers | Recruited and Tissue-Resident Natural Killer Cells in the Lung During Infection and Cancer
Cell therapy industry 2022 - Labiotech.eu
BCCI Focus on Italy 2008_June Edition by Elena Marchese - Issuu
SEC Filing - Kiromic BioPharma, Inc.
MolMed now part of AGC Biologics | LinkedIn
BB Biotech AG - Bold Brilliant biotech investor - QuotedData
424B4
Lorenza Mittempergher PhD | LinkedIn
